Jubilant Generics Limited Atorvastatin Export Data — India (DGFT 2022–2026)

Name: Jubilant Generics Limited Atorvastatin Export Records India — #13 Exporter, 115 Shipments, $5.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Atorvastatin

India Pharmaceutical Trade Intelligence

$1.1B477 Suppliers145 CountriesHS 30049099

ExportsIndia → UNITED STATES52.5%India → CANADA25.9%

ImportsCROATIA → India$3.5M CANADA → India$2.5M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: APOTEX CORP

Jubilant Generics Limited — Atorvastatin Exporter #13 | $5.8M Trade Value | TransData Nexus | TransData Nexus

Jubilant Generics Limited — Atorvastatin Exporter Profile

Indian Pharmaceutical Exporter · #13 for Atorvastatin · $5.8M export value · DGFT Verified

Jubilant Generics Limited is the #13 Indian exporter of Atorvastatin with $5.8M in export value and 115 verified shipments. Jubilant Generics Limited holds a 0.5% market share in Atorvastatin exports across 1 countries. The company exports 6 pharmaceutical products worth $23.9M across 4 therapeutic categories.

Jubilant Generics Limited — Atorvastatin Export Profile: Buyers & Destinations

Jubilant Generics Limited Atorvastatin export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Atorvastatin?

Country	Value	Shipments	Share
UNITED STATES	$194.4M	3,889	50.4%
MALTA	$32.5M	1,226	8.4%
UNITED KINGDOM	$30.2M	1,243	7.8%
CANADA	$29.4M	587

Who Are the Top Buyers of Atorvastatin from India?

Buyer	Country	Value	Orders
APL SWIFT SERVICES (MALTA) LTD.,	MALTA	$25.9M	517
APOTEX CORP	UNITED STATES	$21.4M	429
NOVADOZ PHARMACEUTICALS LLC	UNITED STATES	$17.3M	549
BIOCON PHARMA INC	UNITED STATES	$16.0M	339
YUSEN LOGISTICS BENELUX BELGIUM	BELGIUM	$14.7M	663
LIFESCIENCE LOGISTICS	UNITED STATES	$6.7M	133
MYLAN PHARMACEUTICALS INC,	UNITED STATES	$5.0M	99
ACCORD HEALTHCARE INC.,	CANADA	$850.0K	17
BIOMEDPHARMA	CANADA	$800.0K	16
ASCEND LABOATORIES,LLC C/O UPS	UNITED STATES	$150.0K	3

India's Atorvastatin is purchased by 1,291 buyers worldwide. The top buyer is APL SWIFT SERVICES (MALTA) LTD., (MALTA), followed by APOTEX CORP and NOVADOZ PHARMACEUTICALS LLC.

How Does Jubilant Generics Limited Compare to Nearest Atorvastatin Exporters?

Exporters ranked immediately above and below #13 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
15	ANNORA PHARMA PRIVATE LIMITED	$8.4M	426	1	$19.7K
14	APOTEX RESEARCH PRIVATE LIMITED	$6.2M	124	1	$50.0K
13	JUBILANT GENERICS LIMITED ★	$5.8M	115	1	$50.0K

Jubilant Generics Limited ranks #13 among 477 Indian Atorvastatin exporters. Average shipment value of $50.0K compared to the market average of $657.7K. The closest competitors by value are ANNORA PHARMA PRIVATE LIMITED and APOTEX RESEARCH PRIVATE LIMITED.

Which Indian Ports Ship Atorvastatin Exports?

Port	Shipments	% Share
HYDERABAD ICD	2,042	13.6%
HYDERABAD ICD (INSNF6)	1,131	7.5%
NHAVA SHEVA SEA (INNSA1)	842	5.6%
SAHAR AIR	839	5.6%
JNPT/ NHAVA SHEVA SEA	779	5.2%
DELHI AIR	613	4.1%
SAHAR AIR CARGO ACC (INBOM4)	581	3.9%
HYDERABAD AIR	554	3.7%

Geopolitical & Trade Policy Impact on Jubilant Generics Limited's Atorvastatin Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Jubilant Generics. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential losses estimated between ₹2,500 crore to ₹5,000 crore in March 2026. These disruptions have particularly impacted exports to the Middle East, a key market for Indian pharmaceuticals. (fortuneindia.com)

Conversely, U.S.-China trade tensions have opened avenues for Indian exporters to capture a larger share of the U.S. market. However, recent U.S. tariffs on imports, including pharmaceuticals, pose a risk to this opportunity. The Federation of Indian Export Organisations highlighted that these tariffs could affect nearly 55% of India's exports to the U.S., potentially leading to the loss of longstanding clients. (apnews.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Indian exporters must invest in serialization and traceability systems to meet these stringent regulations, ensuring continued access to the EU market.

Jubilant Generics Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for Jubilant Generics. The company's Roorkee facility's VAI classification by the USFDA in 2024 reflects its adherence to current good manufacturing practices. (business-standard.com) However, the Indian pharmaceutical industry faces ongoing scrutiny regarding quality and compliance. In 2023, the USFDA conducted over 200 inspections in India, with plans to increase this number in 2024, underscoring the need for continuous quality assurance. (fact.net.in)

Additionally, the company has faced legal challenges concerning intellectual property. In March 2025, a court in Uttar Pradesh restrained Jamp Pharma from using Jubilant Generics' confidential data, granting an injunction against copyright infringement. (scconline.com) This case highlights the importance of safeguarding proprietary information in the competitive pharmaceutical landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Jubilant Generics Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 145+ countries, 1,291+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Atorvastatin

Atorvastatin

Jubilant Generics Limited — Atorvastatin Exporter Profile

Jubilant Generics Limited — Atorvastatin Export Profile: Buyers & Destinations

Where Does India Export Atorvastatin?

Who Are the Top Buyers of Atorvastatin from India?

What Is India's Total Atorvastatin Export Value and How Much Does Jubilant Generics Limited Contribute?

What Is the Average Shipment Value for Jubilant Generics Limited's Atorvastatin Exports?

How Does Jubilant Generics Limited Compare to Other Indian Atorvastatin Exporters?

Regulatory Requirements: Exporting Atorvastatin to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Jubilant Generics Limited Compare to Nearest Atorvastatin Exporters?

Which Indian Ports Ship Atorvastatin Exports?

What Other Cardiovascular Products Does Jubilant Generics Limited Export?

Geopolitical & Trade Policy Impact on Jubilant Generics Limited's Atorvastatin Exports

Jubilant Generics Limited — Regulatory Compliance & Quality Standards

About Jubilant Generics Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Atorvastatin Export Data from Jubilant Generics Limited

Atorvastatin Stats

Company Overview

Top Products by Jubilant Generics Limited

Related Analysis

Need Detailed Export Data?

Data Source